TRK-IN-15

• Description :

  TRK-IN-15 is a potent inhibitor of TRK. Protein kinases play a critical role in the control of cell growth and differentiation and are responsible for the control of a wide variety of cellular signal transduction processes. TRK-IN-15 has the potential for the research of TRK-related diseases (extracted from patent WO2012034091A1, compound X-55) [1].

• UNSPSC :

  12352005

• Target :

  Trk Receptor

• Type :

  Reference compound

• Related Pathways :

  Neuronal Signaling; Protein Tyrosine Kinase/RTK

• Applications :

  Cancer-Kinase/protease

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/trk-in-15.html

• Solubility :

  10 mM in DMSO

• Smiles :

  CCNC(C1=CN=C2N1N=C(N3[C@](C4=CC(F)=CC=C4)([H])CCC3)C=C2)=O

• Molecular Formula :

  C19H20FN5O

• Molecular Weight :

  353.39

• References & Citations :

  [1] Yi Fan, et al. Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors. Patent WO2012034091A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1365213-20-2]